IRIS Accounts Production v23.2.0.158 05272633 director 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure052726332022-03-31052726332023-03-31052726332022-04-012023-03-31052726332021-03-31052726332021-04-012022-03-31052726332022-03-3105272633ns16:EnglandWales2022-04-012023-03-3105272633ns15:PoundSterling2022-04-012023-03-3105272633ns11:Director12022-04-012023-03-3105272633ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3105272633ns11:SmallEntities2022-04-012023-03-3105272633ns11:AuditExemptWithAccountantsReport2022-04-012023-03-3105272633ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3105272633ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3105272633ns11:FullAccounts2022-04-012023-03-3105272633ns11:OrdinaryShareClass12022-04-012023-03-3105272633ns11:CompanySecretary12022-04-012023-03-3105272633ns11:RegisteredOffice2022-04-012023-03-3105272633ns6:CurrentFinancialInstruments2023-03-3105272633ns6:CurrentFinancialInstruments2022-03-3105272633ns6:ShareCapital2023-03-3105272633ns6:ShareCapital2022-03-3105272633ns6:RetainedEarningsAccumulatedLosses2023-03-3105272633ns6:RetainedEarningsAccumulatedLosses2022-03-3105272633ns6:LandBuildings2022-03-3105272633ns6:LongLeaseholdAssetsns6:LandBuildings2022-03-3105272633ns6:PlantMachinery2022-03-3105272633ns6:LandBuildings2022-04-012023-03-3105272633ns6:LongLeaseholdAssetsns6:LandBuildings2022-04-012023-03-3105272633ns6:PlantMachinery2022-04-012023-03-3105272633ns6:LandBuildings2023-03-3105272633ns6:LongLeaseholdAssetsns6:LandBuildings2023-03-3105272633ns6:PlantMachinery2023-03-3105272633ns6:LandBuildings2022-03-3105272633ns6:LongLeaseholdAssetsns6:LandBuildings2022-03-3105272633ns6:PlantMachinery2022-03-3105272633ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3105272633ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3105272633ns11:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 05272633 (England and Wales)






















Financial Statements

for the Year Ended 31 March 2023

for

Northstar Lipids (UK) Ltd

Northstar Lipids (UK) Ltd (Registered number: 05272633)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 4


Northstar Lipids (UK) Ltd

Company Information
for the Year Ended 31 March 2023







DIRECTOR: C J Houghton





SECRETARY: K L Houghton





REGISTERED OFFICE: Unit 1a Stirlin Court
Saxilby Enterprise Park
Skellingthorpe Road
Saxilby
Lincolnshire
LN1 2LR





REGISTERED NUMBER: 05272633 (England and Wales)





ACCOUNTANTS: Wright Vigar Limited
Chartered Accountants & Business Advisers
15 Newland
Lincoln
Lincolnshire
LN1 1XG

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Northstar Lipids (UK) Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Northstar Lipids (UK) Ltd for the year ended 31 March 2023 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Northstar Lipids (UK) Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Northstar Lipids (UK) Ltd and state those matters that we have agreed to state to the director of Northstar Lipids (UK) Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Northstar Lipids (UK) Ltd and its director for our work or for this report.

It is your duty to ensure that Northstar Lipids (UK) Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Northstar Lipids (UK) Ltd. You consider that Northstar Lipids (UK) Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Northstar Lipids (UK) Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Wright Vigar Limited
Chartered Accountants & Business Advisers
15 Newland
Lincoln
Lincolnshire
LN1 1XG


27 September 2023

Northstar Lipids (UK) Ltd (Registered number: 05272633)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 71,077 75,063

CURRENT ASSETS
Stocks 1,612,196 1,429,052
Debtors 5 146,174 570,210
Cash at bank 37,888 291,832
1,796,258 2,291,094
CREDITORS
Amounts falling due within one year 6 291,504 899,167
NET CURRENT ASSETS 1,504,754 1,391,927
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,575,831

1,466,990

PROVISIONS FOR LIABILITIES 15,300 12,342
NET ASSETS 1,560,531 1,454,648

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 1,560,431 1,454,548
SHAREHOLDERS' FUNDS 1,560,531 1,454,648

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 September 2023 and were signed by:





C J Houghton - Director


Northstar Lipids (UK) Ltd (Registered number: 05272633)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Northstar Lipids (UK) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Factored revenue is recorded gross of factoring charges.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful
life.
Land- Not deprecated
Leasehold improvements- 20% on reducing balance
Plant and machinery- 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

Northstar Lipids (UK) Ltd (Registered number: 05272633)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. TANGIBLE FIXED ASSETS
Land and Leasehold Plant and
Buildings improvements machinery Totals
£    £    £    £   
COST
At 1 April 2022 9,192 5,446 124,541 139,179
Additions - - 1,553 1,553
Disposals - - (13,238 ) (13,238 )
At 31 March 2023 9,192 5,446 112,856 127,494
DEPRECIATION
At 1 April 2022 - 4,533 59,583 64,116
Charge for year - 228 5,211 5,439
Eliminated on disposal - - (13,138 ) (13,138 )
At 31 March 2023 - 4,761 51,656 56,417
NET BOOK VALUE
At 31 March 2023 9,192 685 61,200 71,077
At 31 March 2022 9,192 913 64,958 75,063

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 141,499 559,009
Other debtors 4,675 11,201
146,174 570,210

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 205,244 841,210
Taxation and social security 64,400 44,184
Other creditors 21,860 13,773
291,504 899,167

7. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Factoring creditor 34,146 332,739

These are secured against factored debts.

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100